WKRN-TV

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect

Risk Statement: There is a reasonable probability that failure to deliver the recommended dose to treat the respiratory symptoms of acute asthma exacerbations such as wheezing coughing, shortness of ...
Seeking Alpha

Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol

BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (AMRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s albuterol sulfate ...
FierceBiotech

FDA Approves Combivent® Respimat® (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chroni

Active ingredients of dual-action Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol now delivered by new propellant-free inhaler RIDGEFIELD, Conn., Oct. 10, 2011 /PRNewswire/ - ...
Yahoo Finance

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

The FDA determined that Amphastar's albuterol is bioequivalent and therapeutically equivalent to Teva Respiratory LLC's ProAir ® HFA (albuterol sulfate) Inhalation Aerosol. Amphastar's CEO and ...
Mena FN

Albuterol Sulfate Inhalation Aerosol Market To Surpass $9.14 Billion By 2030, Growing At A CAGR Of 8.32%: Report By Exactitude Consultancy

The increasing incidence of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) is a significant driver for the Albuterol Sulfate Inhalation Aerosol market. The ...
PharmiWeb

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ("FDA") has granted approval for the Company ...